Asia-Pacific
While IP Australia’s updated manual could be favourable to computer-implemented inventions, stakeholders would like to see whether a consistent and reliable standard is followed during actual examination
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Sponsored
Sponsored
-
Sponsored by Tilleke & GibbinsWith agriculture a vitally important sector of Cambodia’s economy, Sokmean Chea and Vongkhim Lay of Tilleke & Gibbins provide a guide to the registration of new plant varieties in light of significant developments -
Sponsored by Tilleke & GibbinsLinh Duy Mai and Giang Hoang Bach of T&G Law Firm LLC (TGVN), the local associate firm of Tilleke & Gibbins, explain why Decree 147 is to be welcomed, although a key issue is unresolved
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Shipra Alisha Philip of RNA, Technology and IP Attorneys explore the factors driving rapid growth in India's medical tourism industry as fraudulent healthcare providers attempt to cash in
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law examines a new consent agreement system and international trademark partial replacement provisions under South Korea’s revised Trademark Act, and explores the concept of ‘identical trademarks’
-
Sponsored by Saint Island International Patent & Law OfficesFiona Yin of Saint Island International Patent & Law Offices says patent applicants should consider the Accelerated Examination Procedure for Re-examination as it offers an easier application process and quicker patent protection, with no official fee
-
Sponsored by Wanhuida Intellectual PropertyWu Xiaoping of Wanhuida Intellectual Property says the methodology often applied in assessing inventiveness in pharmaceutical patent litigation cases is set to be used in re-examination and invalidation proceedings after the CNIPA makes an invalidation decision a quasi-precedent
